Thrombotic complications of implanted central venous access devices: Prospective evaluation;Complications thrombotiques des chambres à cathéter implantables: Évaluation prospective

Bulletin du Cancer

Volumn 91, Issue 5, 2004, Pages 431-436

  Labourey, Jean Luc ^a   Lacroix, Philippe ^b   Genet, Dominique ^b   Gobeaux, François ^b   Martin, Jean ^b   Venat Bouvet, Laurence ^b   Lavau Denes, Sandrine ^b   Maubon, Antoine ^b   Tubiana Mathieu, Nicole ^b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Chemotherapy; Phlebitis; Thrombosis; Venous access devices

Indexed keywords

SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BREAST TUMOR; CARDIOVASCULAR RISK; CATHETER; CATHETERIZATION; CHEMOTHERAPY; COLON TUMOR; DEVICE; DOPPLER FLOWMETRY; FEMALE; FISHER EXACT TEST; HEAD AND NECK TUMOR; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; NEOPLASM; OCCLUSION; PHLEBITIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; STATISTICAL ANALYSIS; TESTIS TUMOR; THROMBOSIS; URINARY TRACT TUMOR; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 2942541130     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992 ; 49 : 474-8.
2. Torramadé JR, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Gonzales F, et al. The complications of central venous access systems: a study of 218 patients. Eur J Surg 1993 ; 159 : 323-7.
3. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access system: experience in 1,500 patients with totally implanted central venous post-systems. World J Surg 1998 ; 22 : 12-6.
4. Bona RD. Thrombotic complications of central venous catheter in cancer patients. Sem. in thrombosis and hemostasis. Source 1999 ; 25 : 147-55.
5. De Cicco M, Matovic M, Balestteti L, Panatello G, Fantin D, Motassut S, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997 ; 86 : 101-13.
6. Pucheu A, Dierhas M, Leduc B, Sillet-Bach I, Lefort S, Assaf W, et al. Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis. Bull Cancer 1996 ; 83 : 293-9.
7. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994 ; 271 : 1014-6.
8. rd ed. Philadelphia: Lippincott Williams, Wilkins, 1994 ; pp. 1238-54.
9. Petersen J, Delaney JH, Brakstad MT, Rowbothman RK, Bagley CM Jr. Silicone venous access devices positioned with their tip high in the superior vena cava are more likely to malfunction. Am J Surg 2000 ; 178 : 78-9.
10. Luciani A, Clement O, Halimi P, Goudot D, Portiet F, Bassot V, et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 2001 ; 22 : 655-60.
11. Gray BH, Olin JW, Graor RA, Young JR, Bartolomew JR, Ruschhaupt WF. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 1991 ; 99 : 54-9.
12. Théard JL, Lotz JP, Mileron B. Evaluation des protocoles d'utilisation des chambres implantables. Ann Fr Anesth Réan 1995 ; 14 : 534-5.
13. Haire WD, Lynch TG, Lieberman RP, Fernandez JA, DeGregorio C, Tres A, et al. Utility of duplex ultrasound in the diagnosis of asymptomatic catheter induced subclavian vein thrombosis. J Ultrasound Med 1991 ; 10 : 493-6.
14. Pucheu A, Leduc B, Sillet-Bach I, Payen C, Pucheu ME. Deep venous thrombosis on implantable infusion devices. A prospective study of 72 patients with Doppler ultrasonography of veins of the neck (jugular, subclavian and brachiocephalic trunk). Bull Cancer 1993 ; 80 : 680-8.
15. Chait P, Dinyari M, Massicotte P. The sensitivity and specificity of lineograms and ultrasound compared with venography for the diagnosis of central venous line related thrombosis in symptomatic children. The LUV study. Thromb Haemost 2001 ; (abstr P697).
16. Male C, Chait P, Ginsberg JS, Hanna K, Andrew M, Halton J, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children. Results of the PARKAA study. Thromb Haemost 2002 ; 87 : 593-8.
17. Tavecchio L, Bedini AV, Lanocita R, Patelli GL, Donati I, Ravasi G. Long-term infusion in cancer chemotherapy with the Groshong catheter via the inferior vena cava. Tumori 1996 ; 82 : 372-5.
18. De Gregorio MA, Miguelena JM, Fernandez JA, De Gregorio C, Tres A, Alfonso ER. Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients. Eur Radiol 1996 ; 6 : 748-52.
19. Borow M, Crowley JG. Evaluation of central venous catheter thrombogenicity. Acta Anesthesiol Scand 1985 ; 81 : 59-64.
20. Poorter RL, Lauw FN, Benelman WA. Complications of an implantable venous access device during intermittent continuous infusion of chemotherapy. Eur J Cancer 1996 ; 32 : 2262-6.
21. Lokich JL, Becher B. Subclavian vein thrombosis in patients treated with infusions chemotherapy of advanced malignancy. Cancer 1983 ; 52 : 1586-9.
22. Brown DF, Muirhead MJ, Travis PM, Vire SR, Weller J, Hauer-Jensen M. Mode of chemotherapy does not affect complications with implantable venous access device. Cancer 1997 ; 80 : 966-72.
23. Del Campo C, Ing VWK, Millard OH, MacDonald J. Prospective evaluation of a totally implantable drug delivery system improved results at 4-year follow-up. Can J Surg 1991 ; 34 : 278-81.
24. Monreal M, Alastrue A, Rull M, Mira X, Muscart J, Rosell R, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996 ; 75 : 21-3.
25. Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Atkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990 ; 112 : 423-8.
26. Reichardt P, Kretzschmar A, Biakhov M, Irwin D, Slabber C, Millet L, et al. A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight-heparin (dalteparin sodium) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs). Proc Am Soc Clin Oncol 2002 ; 369a : (abstr 1474).
27. Biffi R, De Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsh A, et al. Totally implantable central venous access ports for long-term chemotherapy. Ann Oncol 1998 ; 9 : 767-73.
28. Horattus MC, Wright DJ, Fenton AH, Evans DM, Oddi MA, Kav mieznski RW, et al. Changing concepts of deep venous thrombosis of the upper extremity. Report of a series and review of the literature. Surgery 1988 ; 104 : 561-7.